Santa Fe Community Convention Center Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2011


Here are the related meetings in 2017:
Mononuclear Phagocytes in Health, Immune Defense and Disease (D3)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Dendritic Cells and the Initiation of Adaptive Immunity (J7)


Organizer(s) Ira Mellman, Michel C. Nussenzweig, Virginia Pascual and Federica Sallusto
February 12—17, 2011
Santa Fe Community Convention Center • Santa Fe, New Mexico USA
Abstract Deadline: Oct 13, 2010
Late Abstract Deadline: Nov 17, 2010
Scholarship Deadline: Oct 13, 2010
Early Registration Deadline: Dec 13, 2010

Sponsored by Amgen Inc., Genentech, Inc. and Novo Nordisk A/S


Summary of Meeting:
Current studies of Dendritic Cells (DCs) have confirmed not only their major role as antigen presenting cells in adaptive immunity but also their important functions in maintaining tolerance and in the initiation of the innate resistance and inflammatory responses. Thus, DCs function as an important bridge between innate resistance and adaptive immunity either through cellular interactions or secretion of pro-inflammatory and immunoregulatory cytokines. The origin and migration pattern of DCs, their cell biological mechanisms of action, their functional diversity, their specializations and activities in specific tissue contexts, as well as their sharing of hematopoietic lineages, functions, and receptors with other phagocytic cell types such as monocytes and macrophages are subjects of intense investigation. Increasingly, the role of dendritic cells in disease pathology and as potential therapeutic targets is being explored both in the laboratory and in the clinic. This is particularly true in human cancer, where both active and passive immunotherapies involving dendritic cells are finally being put to the test in a systematic fashion. In this symposium, each of these aspects of dendritic cell biology and immunological function will be explored in detail, including taking a number of “in depth” looks at functions (such as innate activation mechanisms) that are key to understanding how dendritic cells perform their many remarkable tasks. In addition, this symposium will combine and synergize with a second, jointly organized symposium entitled "Cancer Control by Tumor Suppressors and Immune Effectors", thereby emphasizing emerging concepts concerning the role of the immune response in cancer and cancer therapy.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


SATURDAY, FEBRUARY 12

15:00—19:30
Registration

Sweeney Ballroom Foyer
18:15—19:15
Refreshments

Sweeney F, Main Level Breakout Rooms
19:15—21:30
Welcome and Keynote Session (Joint)
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-E
* Laurence Zitvogel, Institut Gustave Roussy, France

Michael Karin, University of California, San Diego, USA
Inflammation, Immunity and Cancer

Jean-Laurent Casanova, Rockefeller University, USA
A Genetic Dissection of Immunity to Infection in Natura


SUNDAY, FEBRUARY 13

07:00—08:00
Breakfast

Sweeney F, Main Level Breakout Rooms
08:00—11:00
Origins of Dendritic Cells
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-B
* Michel C. Nussenzweig, HHMI/Rockefeller University, USA
Title to be Determined

Boris Reizis, New York University Langone Medical Center, USA
Signaling Pathways Regulating Dendritic Cell Development

Steffen Jung, Weizmann Institute of Science, Israel
Differential Functions of Intestinal Mononuclear Phagocytes

Miriam Merad, Mount Sinai School of Medicine, USA
Regulation of Development and Function of Non-Lymphoid Tissue Dendritic Cells

Dimitris Skokos, Regeneron Pharmaceuticals, Inc., USA
Short Talk: Notch Signaling in DC-Treg Cross-Talk and Autoimmunity

08:00—11:00
Pathogenesis: Cancer and Inflammation
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom C-E
Wolf-Hervé Fridman, Cordeliers Research Centre, France
Prognostic Significance of Tumor-Invading Immune Effectors and Regulators in Human Malignancies

* Robert D. Schreiber, Washington University School of Medicine, USA
Molecular Mechanisms Underlying Cancer Immunoediting

Giorgio Trinchieri, NCI, National Institutes of Health, USA
Innate Resistance and Inflammation in Cancer

* Drew M. Pardoll, Johns Hopkins University School of Medicine, USA
STAT3, Th17 and Cancer Progression

Wael Al Zoughbi, Medical University of Graz, Austria
Short Talk: Downregulation of ATGL Enhances Malignant Tumor Growth, ATGL as a Tumor Suppressor Protein

09:20—09:40
Coffee Break

Sweeney F, Main Level Breakout Rooms
11:00—13:00
Poster Setup

Sweeney F, Main Level Breakout Rooms
13:00—22:00
Poster Viewing

Sweeney F, Main Level Breakout Rooms
11:00
On Own for Lunch and Recreation

14:30—16:30
Workshop 1: A DC by Any Other Name Would Still Smell as Sweet

Sweeney Ballroom A-B
* Ken Shortman, Walter and Eliza Hall Institute of Medical Research, Australia

Cheolho Cheong, Rockefeller University, USA
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas

Alicia Rodriguez-Pla, Baylor Institute for Immunology Research, USA
SLE Serum Synergizes with CD14 Signaling in Generation of CCR-7-Expressing Monocyte-Derived DCs

Jay W. Heinecke, University of Washington School of Medicine, USA
The Plasma Membrane Proteome Unravels Macrophage and Myeloid Dendritic Cell Heterogeneity

Florent Ginhoux, Singapore Immunology Network, Singapore
Langerhans Cells Arise from Yolk Sac Primitive Macrophages during Early Embryonic Development

Sandra Bajaña, Oklahoma Medical Research Foundation, USA
Interferon Regulatory Factor 4 Regulates Tissue Dendritic Cell Migration from the Skin during Homeostasis and upon Inflammation in vivo

Molly Ingersoll, Institut Pasteur, France
Analysis of Antigen-Presenting Cell Trafficking from the Bladder to Lymph Nodes

Kang Liu, Columbia University Medical Center, USA
The Steady State Mouse Brain Contains Dendritic Cells that are Functionally Distinct from Microglia

Milena Bogunovic, Pennsylvania State University College of Medicine, USA
Homeostasis and Function of Intestinal Muscularis Dendritic Cells

14:30—16:30
Workshop 1

Sweeney Ballroom C-E
* Mark J. Smyth, QIMR Berghofer Medical Research Institute, Australia

Ana Stojanovic, German Cancer Research Center, Germany
Analysis of Tumor Infiltrating Natural Killer Cells

Philippe D. Pierre, Centre d'Immunologie Marseille-Luminy, CIML, France
Regulated eIF2alpha Dephosphorylation Impairs Translational Stress Responses in Poly I:C -Activated Dendritic Cells

Lionel J. Apetoh, Centre Georges Francois Leclerc, France
Restoration of Anticancer Immune Responses through Selective Inhibition of Myeloid Derived Suppressor Cells

Uciane Kimble Scarlett, Dartmouth College, USA
Progressive Abrogation of Early Anti-Tumor Immunity by Dendritic Cells Provides New Opportunities for Novel Diagnostic Interventions

Jennifer C. Byrne, Royal College of Surgeons in Ireland, Ireland
Knock-Out of BTK May Promote a Tumor Tolerogenic State through Alteration of TLR Signalling

Liat Izhak, National Cancer Institute, National Institutes of Health, USA
The Relative Role of Two Types of Regulatory T Cells in Tumor Immunity : Tregs and Type II NKT Cells

George Coukos, University Hospital of Lausanne - CHUV, Switzerland
CCR10+ Regulatory T Cells are Recruited by Hypoxic Tumor Cells via the CCL28 Chemokine to Promote Immune Tolerance and Angiogenesis in Cancer

16:30—17:00
Coffee Available

Sweeney F, Main Level Breakout Rooms
17:00—19:15
Mechanisms of Antigen Processing by Dendritic Cells
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-B
* Ira Mellman, Genentech, Inc., USA
Endosomes and Antigen Presentation by Dendritic Cells

Hidde L. Ploegh, Boston Children's Hospital, USA
Title to be Determined

Sebastian Amigorena, Institut Curie, France
Antigen Cross Presentation in DCs

Pierre Guermonprez, Kings College London, UK
Short Talk

17:00—19:00
Innate Immunity Against Cancer
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom C-E
Vassili Soumelis, Institut Curie, France
Plasmacytoid DC-Tumor Interactions in Humans

Carl G. Figdor, Radboud University Medical Center, Netherlands
Human Plasmacytoid DC in Cancer and Cancer Immunotherapy

* Mark J. Smyth, QIMR Berghofer Medical Research Institute, Australia
NK/NKT Cell Receptor-Mediated Immunosurveillance

Stephen B. Willingham, Corvus Pharmaceuticals, USA
Short Talk: Efficacy of Anti-CD47 Antibody Therapy for Human Solid Tumors

19:00—20:00
Social Hour with Lite Bites

Sweeney F, Main Level Breakout Rooms
19:30—22:00
Poster Session 1

Sweeney F, Main Level Breakout Rooms

MONDAY, FEBRUARY 14

07:00—08:00
Breakfast

Sweeney F, Main Level Breakout Rooms
08:00—11:15
Harnessing the Cell Biology of Dendritic Cells against Cancer (Joint)
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-E
* Federica Sallusto, University of Italian Switzerland, Switzerland

Yong-Jun Liu, Sanofi, USA
Identification of DNA/RNA Sensors in DCs

Caetano Reis e Sousa, Francis Crick Institute, UK
Harnessing DC Biology Against Cancer

Madhav V. Dhodapkar, Yale School of Medicine, USA
Dual Face of DCs in Cancer

Jolanda de Vries, NCMLS, Radboud University Medical Center, Netherlands
Short Talk: Imaging Early Immune Responses in Cancer Patients after DC Vaccination

Kangling Xu, Baylor Institute for Immunology Research, USA
Short Talk: TSLP Driven Inflammation Fosters Breast Tumor Development

Christopher E. Rudd, University of Montreal, Canada
Short Talk: CTLA-4 Modulation of T-Cell-DC Interactions

Hideki Ueno, Icahn School of Medicine at Mount Sinai, USA
Short Talk: Generation of T Follicular Helper Cells by DCs in Humans

09:20—09:40
Coffee Break

Sweeney F, Main Level Breakout Rooms
11:15—13:00
Poster Setup

Sweeney F, Main Level Breakout Rooms
13:00—22:00
Poster Viewing

Sweeney F, Main Level Breakout Rooms
11:15
On Own for Lunch and Recreation

14:30—16:30
Workshop 2: Antigen Processing and Presentation

Sweeney Ballroom A-B
* Jose A. Villadangos, University of Melbourne, Australia

* Philippe D. Pierre, Centre d'Immunologie Marseille-Luminy, CIML, France

Amanda L. Blasius, Novo Nordisk Research Center, USA
Slc15a4, AP-3 and Hermansky-Pudlak Syndrome Proteins are Required for TLR Signaling in Plasmacytoid Dendritic Cells

Misako Matsumoto, Hokkaido University Graduate School of Medicine, Japan
Raftlin is Essential for Poly(I:C) Cellular Uptake in Human Myeloid Dendritic Cells

Diana Matheoud, Université de Montréal, Canada
Dendritic Cells Acquire Antigens Through a New Mechanism of Endocytosis Involving Gap Junctions

Adriana R. Mantegazza, University of Pennsylvania School of Medicine, USA
Adaptor Protein 3 (AP-3) Regulates Processing of Phagocytosed Antigen for Presentation by MHC Class II Molecules

Berta Bosch, National Cancer Institute, National Institutes of Health, USA
Clustering Enhances the Quality of MHC-II-Peptide Complex-Stimulation of CD4 T Lymphocytes by Dendritic Cells

Erika Darrah, Johns Hopkins University, USA
Cleavage of Peptidyl Arginine Deiminase IV by Granzyme B Induces Discrete Structural Changes and Influences Epitope Selection

Guenther Baravalle, University of California, San Francisco, USA
MARCH1-Mediated Ubiquitination Regulates CD86 Expression in Dendritic Cells in the Steady and Inflammatory States

Jessica Ma, Genentech, USA
Ubiquitination Regulates MHC-II Transport in Antigen Presenting Cells

14:30—16:30
Workshop 2: Immune Status Response at Different Stages of Tumor Development and Progression

Sweeney Ballroom C-E
* A. Karolina Palucka, Tha Jackson Laboratory for Genomic Medicine, USA

Kenneth Nally, University College Cork, Ireland
Regulation of a Putative Tumor Suppressor Gene BCL-G by Pro Inflammatory Cytokines in Intestinal Epithelial Cells

Stefanie Regine Dannenmann, University Hospital Zürich, Switzerland
Immunoregulation of Tumor-Specific T Cell Responses in Clear Cell Renal Cell Carcinoma (ccRCC)

Joseph E. Qualls, St. Jude Children's Research Hospital, USA
Tumor Infiltrating Macrophages Acquire Similar Traits Independent of Tumor Type and Location

Dinesh Chandra, Albert Einstein College of Medicine, USA
Listeria Takes Control Over MDSC in the Tumor Microenvironment and Improves Anti-Tumor Immunity

Brent A. Hanks, Duke University Medical Center, USA
Loss of the Type III TGF-beta Receptor Tumor Suppressor during Breast Cancer Progression Generates an Immunotolerant Tumor Microenvironment

Eric R. Lutz, Johns Hopkins University, USA
Higher Avidity Mesothelin-Specific CD8+ T Cell Repertoires are Associated with Longer Disease-Free Survival and Tumor-Trafficking in Patients Treated with a GM-CSF-Secreting Pancreatic Tumor Vaccine

16:30—17:00
Coffee Available

Sweeney F, Main Level Breakout Rooms
17:00—19:00
Mechanisms and Consequences of Antigen Presentation by Dendritic Cells
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-B
* Michel C. Nussenzweig, HHMI/Rockefeller University, USA

Gillian Griffiths, Cambridge Institute for Medical Research, UK
Innate to Adaptive: How to Deliver the Lethal Hit

Bali Pulendran, Emory University, USA
Learning Immunology from Successful Vaccines

Anna Smed Sörensen, Karolinska Institutet, Sweden
Short Talk: Influenza A Virus Infection of Human Primary Dendritic Cells Impairs their Ability to Cross-Present Antigen to CD8 T Cells

Gerben Bouma, Institute of Child Health, UK
Short Talk: Cytoskeletal Remodelling Mediated by WASp in DC is Required for Formation and Function of the Immunological Synapse

17:00—19:00
Adaptive Immunity against Cancer?
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom C-E
Richard A. Flavell, HHMI, Yale University School of Medicine, USA
The Role of Inflammasome in Cancer

* Glenn Dranoff, Novartis Institutes for BioMedical Research, USA
Mechanisms of Protective Tumor Immunity

Nicholas P. Restifo, NCI, National Institutes of Health, USA
Adoptive Transfer of “Stem Cell-Like” Anti-Tumor T Cells can Eradicate Tumors

Li Wang, Medical College of Wisconsin, USA
Short Talk: VISTA, a Novel Ig-Superfamily Ligand that Negatively Regulates T Cell Responses

19:00—20:00
Social Hour with Lite Bites

Sweeney F, Main Level Breakout Rooms
19:30—22:00
Poster Session 2

Sweeney F, Main Level Breakout Rooms

TUESDAY, FEBRUARY 15

07:00—08:00
Breakfast

Sweeney F, Main Level Breakout Rooms
08:00—11:15
Dendritic Cells in Tolerance, Inflammation and Autoimmunity
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-B
* Virginia Pascual, Baylor Research Institute, USA
Neutrophil-Induced pDC Activation in SLE

Fiona M. Powrie, University of Oxford, UK
Gut Reactions: Dendritic Cells in the Intestine in Health and Disease

Federica Sallusto, University of Italian Switzerland, Switzerland
Monocytes as Antigen Presenting Cells for Induction of T Cell Response to Microbes

Julie Magarian Blander, Weill Cornell Medicine, Cornell University, USA
Infection and Apoptosis as a Combined Inflammatory Trigger

Mirjam Kool, Erasmus MC, Netherlands
Short Talk: The Ubiquitin Modifying Enzyme A20 is Essential for Suppressing Dendritic Cell Activation and Systemic Autoimmunity

08:00—11:00
Clearance of Dying Cells
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom C-E
Kodi S. Ravichandran, University of Virginia, USA
Signaling to Engulfment: The Beginnings of a Good Apoptotic Meal

Shigekazu Nagata, IFReC, Osaka University, Japan
Apoptosis and Autoimmunity

* Douglas R. Green, St. Jude Children's Research Hospital, USA
How Caspase-8 Keeps Cells and Mice Alive

Dean Walton Felsher, Stanford University, USA
Essential Role for CD4+ T-Cells in Oncogene Addiction

Yi Feng, University of Bristol, UK
Short Talk: Live Imaging of Innate Immune Cell Sensing of Transformed Cells in Zebrafish Larvae: Initiation of a “Trophic” Inflammatory Response

09:20—09:40
Coffee Break

Sweeney F, Main Level Breakout Rooms
11:15—13:00
Poster Setup

Sweeney F, Main Level Breakout Rooms
13:00—22:00
Poster Viewing

Sweeney F, Main Level Breakout Rooms
11:00
On Own for Lunch and Recreation

16:30—17:00
Coffee Available

Sweeney F, Main Level Breakout Rooms
17:00—19:00
Sensing Innate Signals by Dendritic Cells and Other Cells
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-B
* Federica Sallusto, University of Italian Switzerland, Switzerland

Matthew Collin, Newcastle University, UK
Dendritic Cell Immunodeficiency in Humans

Jürg Tschopp, University of Lausanne, Switzerland
Inflammasomes

Christian Münz, University of Zurich, Switzerland
Short Talk: Macroautophagy in Antigen Processing for MHC Presentation

Kenya Honda, School of Medicine, Keio University, Japan
Short Talk: Commensal Bacteria-Mediated Treg Induction

Nicolas Chevrier, Harvard University, USA
Short Talk: Systematic Discovery of Signaling Components Identifies New Branches in Mammalian Viral-Sensing Pathways

17:00—19:15
Immunosuppressive Components
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom C-E
Laurence Zitvogel, Institut Gustave Roussy, France
Unraveling the Key-Lock Paradigm of the Immunogenicity of Cell Death

Mario P. Colombo, Fondazione IRCCS Istituto Nazionale Tumori, Italy
Cells and Matricellular Proteins Accomplices in Tumor Development

Ursula Grohmann, University of Perugia, Italy
Spotlight on IDO: Tryptophan Catabolism and Beyond

John Stagg, University of Montréal, Canada
Short Talk: Host-Derived and Tumor-Derived CD73 Promotes Immune Escape and Metastasis

Lionel J. Apetoh, Centre Georges Francois Leclerc, France
Short Talk: CD39 and CD73 Expression on Th17 Cells Suppress Antitumor Immunity

19:00—20:00
Social Hour with Lite Bites

Sweeney F, Main Level Breakout Rooms
19:30—22:00
Poster Session 3

Sweeney F, Main Level Breakout Rooms

WEDNESDAY, FEBRUARY 16

07:00—08:00
Breakfast

Sweeney F, Main Level Breakout Rooms
08:00—11:15
Dendritic Cells in situ: Function and Biology
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-B
* Ira Mellman, Genentech, Inc., USA

Maria Rescigno, European Institute of Oncology, Italy
DCs in Intestinal Disease and in Cancer Immunotherapy

Bart N. Lambrecht, VIB, Ghent University, Belgium
Airway Dendritic Cell Biology

Hiroshi Ohno, RIKEN Research Center for Allergy and Immunology, Japan
Short Talk: M Cells and Antigen Delivery to DCs in the Gut

Frederic Geissmann, Memorial Sloan Kettering Cancer Center, USA
Diseases of DCs in Humans

Shannon J. Turley, Genentech, Inc., USA
Regulation of DC Motility by Podoplanin Activation of Clec2

Jun Lu, Brigham and Women's Hospital, USA
Short Talk: Dynamic Regulation of E-Cadherin on Myeloid DC Induces Ras and Potent T Cell Activation

08:00—11:15
Cancer Vaccines: Prophylaxy or Therapy
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom C-E
* A. Karolina Palucka, Tha Jackson Laboratory for Genomic Medicine, USA
DC Vaccine Update

Giorgio Parmiani, Fondazione Centro San Raffaele Del MonteTabor, Italy
Peptide-Based Vaccine Update

Vincent G. Brichard, GlaxoSmithKline Biologicals, Belgium
Development of the MAGE-A3 ASCI: From Tumor Specificity to Predictive Biomarkers

Tibor P. Keler, Celldex Therapeutics, Inc., USA
DC Targeting in Humans

Asís Palazón, CIMA, Spain
Short Talk: Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes

Lotte Pyfferoen, Ghent University, Belgium
Short Talk: Multilevel Immunomodulation in an Orthotopic Mouse Model of Lung Cancer with Emphasis on Dendritic Cells

09:00—09:20
Coffee Break

Sweeney F, Main Level Breakout Rooms
11:15
On Own for Lunch and Recreation

14:30—16:30
Workshop 3: Perspectives on Breaking Tolerance in Cancer Immunotherapy

Sweeney Ballroom C-E
* Laurence Zitvogel, Institut Gustave Roussy, France

Alison Clare West, Peter MacCallum Cancer Centre, Australia
Anti-Cancer Therapy Mediated by a Histone Deacytelase Inhibitor Engages the Immune System

Saskia J.A.M. Santegoets, VU University Medical Center, Netherlands
The Induction of Autoantibodies to PSMA, PNPO and NRP2 Correlates with Clinical Outcome in Patients Treated with Prostate GVAX/Anti-CTLA-4 Immunotherapy

Anita Stam, VU University Medical Center, Netherlands
Increased Type-2/Th17 T Cell Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX/anti-CTLA-4 Immunotherapy

Jose A. Villadangos, University of Melbourne, Australia
Antigen Presentation by Tumor Cells, not by DC nor GR1+CD11b+ Cells, Rapidly Impairs Adoptive Anti-Lymphoma CTL Therapy

Rikke Sick Andersen, University of Southern Denmark, Denmark
T-Cell Specificities of Tumor-Infiltrating Lymphocytes from Patients with Malignant Melanoma

Alexandre Johannsen, CHUV, Switzerland
Definition of Key Variables for the Induction of Optimal NY-ESO-1-Specific T Cells in HLA Transgene Mice

Toby Lawrence, INSERM, France
IkappaB Kinase (IKK)beta Activation in Macrophages Maintains Tumor-Induced Immune Tolerance

Monique H. M. Melis, Netherlands Cancer Institute, Netherlands
Development of a Doxycycline-Dependent Caspase 3 Death Switch Model to Assess the Host Immune Response to Rapid and Synchronous Tumor Cell Apoptosis in vivo

16:30—17:00
Coffee Available

Sweeney F, Main Level Breakout Rooms
17:00—19:00
Translating Immune Responses Toward and Into the Clinic (Joint)
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-E
* Virginia Pascual, Baylor Research Institute, USA

Robert A. Seder, NIAID, National Institutes of Health, USA
TLRs in Vaccine Development

Gerold Schuler, University Hospital of Erlangen, Germany
Monocyte-Derived Dendritic Cells in Cancer Immunotherapy

Lei Zheng, Johns Hopkins University School of Medicine, USA
Regulatory T Cells and their Role in the Tumor Micro-Environment

19:00—20:00
Closing Keynote Address (Joint)
Meeting has ended...abstracts no longer viewable online.

Sweeney Ballroom A-E
* Ira Mellman, Genentech, Inc., USA

Ralph M. Steinman, Rockefeller University, USA
In vivo Veritas in Humans

20:00—21:00
Social Hour with Lite Bites

Sweeney F, Main Level Breakout Rooms
20:00—23:00
Entertainment

Sweeney F, Main Level Breakout Rooms

THURSDAY, FEBRUARY 17

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



We gratefully acknowledge additional support for this conference from:


Genentech, Inc.

Educational donation provided by Amgen Genentech, Inc.
Novo Nordisk A/S
 

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13AI092851-01




We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Assistant Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676